The aggregated tau found in the brains of Alzheimer's disease patients is known to have a β-sheet structure, and tau aggregation can be monitored in vitro by measuring changes in the fluorescence intensity of thioflavin T binding to the β-sheet structure [12]. Here, MAPT is linked to Alzheimer disease.